Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Product sales, net $ 3,606 $ 4,002
Cost of goods sold 1,948 2,149
Gross profit 1,658 1,853
Operating expenses:    
Research and development 30 36
Selling, general and administrative 2,139 2,437
Benefit from reversal of accrued payroll taxes (522) 0
Total operating expenses 1,647 2,473
Operating income (loss) 11 (620)
Gain on extinguishment of debt (38) 0
Other expense, net 151 2
Loss before income taxes (102) (622)
Income tax expense 7 6
Net income (loss) $ (109) $ (628)
Weighted average common shares outstanding, basic (in shares) 184,264 163,075
Weighted average common shares outstanding, diluted (in shares) 184,264 163,075
Net income (loss) per common share, basic (in USD per share) $ (0) $ (0)
Net income (loss) per common share, basic diluted (in USD per share) $ (0) $ (0)
Revenue, product and service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember